For patients with systemic lupus erythematosus (SLE), fewer than one-quarter meet criteria for major clinical response (MCR) after treatment escalation, with Black patients less likely to meet MCR criteria than white patients, according to a study published online Nov. 2 in The Lancet Rheumatology.